H.R. 5189
Referred to CommitteeOpioid Abuse Crisis Act of 2016
Latest Action
Referred to the Subcommittee on Military Personnel.
6/7/2016 • House
Summary
Opioid Abuse Crisis Act of 2016
This bill appropriates funding for activities in this bill.
This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide support for activities related to opioid abuse, including treatment services. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
This bill amends the Controlled Substances Act, including to permit a pharmacist to partially fill a prescription for certain drugs.
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to refer new drug applications for opioids without abuse deterrent properties to an advisory committee.
This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to permit the Department of Justice (DOJ) to support opioid abuse services and programs for veterans.
Opioid Program Evaluation Act or the OPEN Act
DOJ and HHS must have a nonfederal entity evaluate the grants established by this bill.
Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act
The Department of Veterans Affairs (VA) and the Department of Defense (DOD) must update the VA/DOD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain.
The VA must carry out activities related to opioid abuse, including expanding the opioid safety initiative to include all VA medical facilities.
Improving Safe Care for the Prevention of Infant Abuse and Neglect Act
The national clearinghouse for child abuse information must provide information on plans of safe care for infants born affected by substance abuse.
This bill amends the Social Security Act, including to permit prescription drug plan sponsors to establish programs for beneficiaries at-risk for prescription drug abuse.Introduced in House • 5/11/2016
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (1)
Sponsor
No cosponsors yet
Cosponsors may be added as the bill moves through Congress
Bill Journey
Originated in the House
Introduced
May 11, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Veterans' Affairs, Education and the Workforce, Ways and Means, Armed Services, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (23)
S. 2872
NAS Healthy Babies Act
H.R. 4586
Lali's Law
H.R. 1818
Veteran Emergency Medical Technician Support Act of 2016
H.R. 4599
Reducing Unused Medications Act of 2016
H.R. 4969
John Thomas Decker Act of 2016
H.R. 4976
Opioid Review Modernization Act of 2016
H.R. 4983
To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.
H.R. 5048
Good Samaritan Assessment Act of 2016
H.R. 5052
OPEN Act
H.R. 271
COVER Act
H.R. 2298
Medicare Patient Safety and Drug Abuse Prevention Act
H.R. 3680
Co-Prescribing to Reduce Overdoses Act of 2016
H.R. 3691
Improving Treatment for Pregnant and Postpartum Women Act of 2016
H.R. 4063
Jason Simcakoski PROMISE Act
H.R. 4843
Infant Plan of Safe Care Improvement Act
H.R. 4981
Opioid Use Disorder Treatment Expansion and Modernization Act
H.R. 4982
Examining Opioid Treatment Infrastructure Act of 2016
H.R. 5046
Comprehensive Opioid Abuse Reduction Act of 2016
S. 3015
John Thomas Decker Act of 2016
H.R. 4978
NAS Healthy Babies Act
H.R. 5145
To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.
H.R. 5216
Opioid and Heroin Abuse Crisis Investment Act of 2016
S. 3223
Expanded Access to Treatment and Recovery Act
Committees
Armed Services Committee
House
Veterans' Affairs Committee
House
Judiciary Committee
House
Natural Resources Committee
House
Ways and Means Committee
House
Energy and Commerce Committee
House
Education and Workforce Committee
House